Sai Parenteral's (NSE:SAIPARENT) Total Tax Payable: ₹0 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SAIPARENT Sai Parenteral's Ltd NSE:SAIPARENT
14 GF Score
Price ₹569.70
! 7 Warning Signs
View Full Analysis

What is Sai Parenteral's Total Tax Payable?

Sai Parenteral's NSE:SAIPARENT +5.28% 14 Total Tax Payable is ₹0 Mil as of Sep. 2025. GuruFocus rates NSE:SAIPARENT with a GF Score™ of 14/100. The stock has 7 warning signs investors should review.

Sai Parenteral's's Total Tax Payable for the quarter that ended in Sep. 2025 was ₹0 Mil.

Sai Parenteral's's quarterly Total Tax Payable declined from Mar. 2024 (₹41 Mil) to Mar. 2025 (₹0 Mil) but then stayed the same from Mar. 2025 (₹0 Mil) to Sep. 2025 (₹0 Mil).

Sai Parenteral's's annual Total Tax Payable increased from Mar. 2023 (₹21 Mil) to Mar. 2024 (₹41 Mil) but then declined from Mar. 2024 (₹41 Mil) to Mar. 2025 (₹0 Mil).

Sai Parenteral's Total Tax Payable Related Terms

Sai Parenteral's Total Tax Payable Historical Data

* Premium members only.

The historical data trend for Sai Parenteral's's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sai Parenteral's Total Tax Payable Chart

Sai Parenteral's Annual Data
Trend Mar23 Mar24 Mar25
Total Tax Payable
21.42 40.98 0.00

Sai Parenteral's Semi-Annual Data
Mar23 Mar24 Mar25 Sep25
Total Tax Payable 21.42 40.98 0.00 0.00
NSE:SAIPARENT
14GF Score
Sai Parenteral's Ltd NSE:SAIPARENT
Total Tax Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sai Parenteral's Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of ₹0 Mil mean?
Sai Parenteral's (NSE:SAIPARENT) has a Total Tax Payable of ₹0 Mil as of Sep. 2025. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Sai Parenteral's and its competitors.
Is Sai Parenteral's' Total Tax Payable too high?
Sai Parenteral's' current Total Tax Payable is ₹0 Mil. Overall, Sai Parenteral's has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Sai Parenteral's' Total Tax Payable compare to LLY and JNJ?
Sai Parenteral's' Total Tax Payable of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Drug Manufacturers company?
A good Total Tax Payable depends on the Drug Manufacturers industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Sai Parenteral's and its competitors. Sai Parenteral's's current Total Tax Payable is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sai Parenteral's stock overvalued right now?
Sai Parenteral's (NSE:SAIPARENT) has a current Total Tax Payable of ₹0 Mil. The current Total Tax Payable is ₹0 Mil. Sai Parenteral's' overall GF Score™ is 14/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For Sai Parenteral's (NSE:SAIPARENT), the current Total Tax Payable is ₹0 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sai Parenteral's Business Description

Other Exchanges 544742:India
Address Plot No 39, 5th floor, Lavanya Arcade Jayabheri Enclave, Gachibowli, K.V.Rangareddy, Seri Lingampally, Hyderabad, TG, IND, 500032
Sai Parenteral's Ltd is a diversified pharmaceutical formulations company. Its business is organised in two verticals: (i) Branded Generic Formulations: Through the branded generics portfolio, it serves the domestic market with formulations across multiple therapeutic areas. and (ii) Contract Development and Manufacturing Organisation (CDMO): It provides CDMO services to pharmaceutical companies, supporting activities from product development to commercial manufacturing. Its product portfolio includes cardiovascular care, neuropsychiatry, anti-diabetic therapy, respiratory health, antibiotics, gastroenterology, vitamins, etc. The majority of the company's revenue is derived from the Branded Generic Formulations business.
14GF Score

Get the complete analysis for NSE:SAIPARENT

Total Tax Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹569.70
Price